| References |
| 1 |
Nattel S, Ranger S, Talajic M, et al "Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism." Am J Med 89 (1990): 235-8. [PMID: 2382671]
|
| 2 |
Product Information. Azithromycin Product Information (azithromycin). Pfizer US Pharmaceuticals, New York, NY.
|
| 3 |
Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
|
| 4 |
Product Information. Erythrocin Lactobionate (erythromycin). Abbott Pharmaceutical, Abbott Park, IL.
|
| 5 |
Samarendra P, Kumari S, Evans SJ, Sacchi TJ, Navarro V "QT prolongation associated with azithromycin/amiodarone combination." Pacing Clin Electrophysiol 24 (2001): 1572-4. [PMID: 11707055]
|
| 6 |
Trivier JM, Libersa C, Belloc C, Lhermitte M "Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report)." Life Sci 52 (1993): pl91-6. [PMID: 8445979]
|
| 7 |
Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
|